Duration of anticoagulation treatment in patients with venous thromboembolism

Scott Kaatz, Waqas Qureshi, Christopher Fain, David Paje

Research output: Contribution to journalArticle

Abstract

Deep vein thrombosis and pulmonary embolism are clinical manifestations of venous thromboembolism, and they necessitate anticoagulant therapy in most cases. The duration of treatment is predicated on a balance between the risk of recurrent disease and the risk of bleeding inherent to anticoagulant therapy. It is important that physicians are aware of evidence-based guidelines that can enhance decision-making discussions with patients about the risks and benefits of the different durations of treatment. Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care.

Original languageEnglish (US)
Pages (from-to)638-644
Number of pages7
JournalJournal of the American Osteopathic Association
Volume110
Issue number11
StatePublished - Nov 2010

Fingerprint

Venous Thromboembolism
Anticoagulants
Therapeutics
Pulmonary Embolism
Venous Thrombosis
Compliance
Decision Making
Guidelines
Hemorrhage
Physicians

ASJC Scopus subject areas

  • Complementary and alternative medicine
  • Medicine(all)

Cite this

Duration of anticoagulation treatment in patients with venous thromboembolism. / Kaatz, Scott; Qureshi, Waqas; Fain, Christopher; Paje, David.

In: Journal of the American Osteopathic Association, Vol. 110, No. 11, 11.2010, p. 638-644.

Research output: Contribution to journalArticle

@article{e2cd77bbc9734d168191b92171a2c484,
title = "Duration of anticoagulation treatment in patients with venous thromboembolism",
abstract = "Deep vein thrombosis and pulmonary embolism are clinical manifestations of venous thromboembolism, and they necessitate anticoagulant therapy in most cases. The duration of treatment is predicated on a balance between the risk of recurrent disease and the risk of bleeding inherent to anticoagulant therapy. It is important that physicians are aware of evidence-based guidelines that can enhance decision-making discussions with patients about the risks and benefits of the different durations of treatment. Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care.",
author = "Scott Kaatz and Waqas Qureshi and Christopher Fain and David Paje",
year = "2010",
month = "11",
language = "English (US)",
volume = "110",
pages = "638--644",
journal = "The Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "11",

}

TY - JOUR

T1 - Duration of anticoagulation treatment in patients with venous thromboembolism

AU - Kaatz, Scott

AU - Qureshi, Waqas

AU - Fain, Christopher

AU - Paje, David

PY - 2010/11

Y1 - 2010/11

N2 - Deep vein thrombosis and pulmonary embolism are clinical manifestations of venous thromboembolism, and they necessitate anticoagulant therapy in most cases. The duration of treatment is predicated on a balance between the risk of recurrent disease and the risk of bleeding inherent to anticoagulant therapy. It is important that physicians are aware of evidence-based guidelines that can enhance decision-making discussions with patients about the risks and benefits of the different durations of treatment. Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care.

AB - Deep vein thrombosis and pulmonary embolism are clinical manifestations of venous thromboembolism, and they necessitate anticoagulant therapy in most cases. The duration of treatment is predicated on a balance between the risk of recurrent disease and the risk of bleeding inherent to anticoagulant therapy. It is important that physicians are aware of evidence-based guidelines that can enhance decision-making discussions with patients about the risks and benefits of the different durations of treatment. Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care.

UR - http://www.scopus.com/inward/record.url?scp=79953156568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953156568&partnerID=8YFLogxK

M3 - Article

VL - 110

SP - 638

EP - 644

JO - The Journal of the American Osteopathic Association

JF - The Journal of the American Osteopathic Association

SN - 0098-6151

IS - 11

ER -